• Emphasises its compliance with NMRA regulations

Refuting the allegations levelled against pharmaceutical companies by Minister of Health Dr. Nalinda Jayatissa at the Parliament recently, pharma company, Divesa Pharma Limited, stated in a press release that it was issued a licence “to sell medicine by wholesale by the National Medicines Regulatory Authority (NMRA) on 18 August 2018, which has been continuously renewed to date.”

Divasa Pharma Limited, providing factual clarity on the recent allegations stated that it has been a local authorised distributor of George Steuart Health (Pvt.) Limited for some of its products, including Covid-19 PCR and RAT kits. Divasa Pharma Ltd. is a company incorporated in 2012, the statement clarified.

“As such, Divasa Pharma has legitimately marketed and sold Covid-19 PCR and RAT kits to the local market including to public healthcare institutions and private healthcare institutions, under guidelines issued by the Ministry of Health. These PCR and RAT Kits were sold at the NMRA stipulated price or less,” the company said in a statement.

The pharma company highlighted that it participated in a transparent tender

procurement process, and fulfilled “all necessary requirements” as a local authorised

distributor of such products, the statement said.